- Home
- ONCY vs INVE Comparison
ONCY vs INVE Comparison
Compare ONCY & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- INVE
- Stock Information
- Founded
- ONCY 1998
- INVE 1990
- Country
- ONCY Canada
- INVE United States
- Employees
- ONCY N/A
- INVE N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- INVE Computer peripheral equipment
- Sector
- ONCY Health Care
- INVE Technology
- Exchange
- ONCY Nasdaq
- INVE Nasdaq
- Market Cap
- ONCY 89.7M
- INVE 86.7M
- IPO Year
- ONCY 1999
- INVE 1997
- Fundamental
- Price
- ONCY $1.06
- INVE $3.70
- Analyst Decision
- ONCY Strong Buy
- INVE Strong Buy
- Analyst Count
- ONCY 5
- INVE 2
- Target Price
- ONCY $5.00
- INVE $5.50
- AVG Volume (30 Days)
- ONCY 681.0K
- INVE 47.1K
- Earning Date
- ONCY 08-08-2025
- INVE 08-07-2025
- Dividend Yield
- ONCY N/A
- INVE N/A
- EPS Growth
- ONCY N/A
- INVE N/A
- EPS
- ONCY N/A
- INVE 3.12
- Revenue
- ONCY N/A
- INVE $23,538,000.00
- Revenue This Year
- ONCY N/A
- INVE N/A
- Revenue Next Year
- ONCY N/A
- INVE $9.98
- P/E Ratio
- ONCY N/A
- INVE $1.19
- Revenue Growth
- ONCY N/A
- INVE N/A
- 52 Week Low
- ONCY $0.33
- INVE $2.86
- 52 Week High
- ONCY $1.53
- INVE $4.29
- Technical
- Relative Strength Index (RSI)
- ONCY 54.04
- INVE 55.50
- Support Level
- ONCY $0.95
- INVE $3.49
- Resistance Level
- ONCY $1.07
- INVE $3.94
- Average True Range (ATR)
- ONCY 0.08
- INVE 0.18
- MACD
- ONCY 0.01
- INVE 0.00
- Stochastic Oscillator
- ONCY 81.89
- INVE 51.02
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.